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ABSTRACT 
Staphylococcus aureus is one of the most common causes of infection and has been rapidly 
developing drug resistance, making the discovery of a new drug target imperative. This 
project analyzed the interaction between heme and IsdG, a heme degrading enzyme involved in 
the spread of S. aureus, to gain further insight into the mechanism of heme degradation. Iron serves 
as an essential nutrient for S. aureus, and IsdG is the primary enzyme involved in iron acquisition 
from heme. IsdG has a catalytic pocket that contains tryptophan at residue 67 that is expected to 
be involved in heme ruffling. The W67F variant of IsdG formed with site-directed mutagenesis 
was expected to ruffle and degrade heme to a lesser extent being that Trp is replaced with a less 
bulky amino acid, Phenylalanine (Phe, F). The variant was characterized using Electronic 
Absorption (Abs), Ultraviolet Circular Dichroism (UV CD), and Magnetic Circular Dichroism 
(MCD) spectroscopies to analyze changes to the geometric and electronic structure resulting from 
the substitution. The CD spectra confirmed similar geometric structures of W67F and wild-type 
(WT) IsdG. The activity of W67F differed from that of WT IsdG, indicating that Trp67 is involved 
in the enzyme’s activity and promotes IsdG turnover. The Abs spectra showed a blue-shift in the 
Q and Soret bands of W67F IsdG indicating reduced heme ruffling and that Trp67 was involved 
in heme ruffling. The increased intensity of the negative-component of the Soret band in the MCD 
spectrum of W67F IsdG was indicative of a 2Eg electronic ground state, consistent with reduced 
heme ruffling. Being that Trp67 is an active site residue specific to the IsdG family of non-
canonical heme oxygenases (HOs), this information regarding the influence of Trp67 on heme 
ruffling and IsdG activity is crucial to the development of a selective inhibitor of IsdG in the 
presence of canonical HOs. 
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ABBREVIATIONS 
Abs   Electronic absorption 
CD   Circular Dichroism 
DTT   Dithiothreitol 
EDTA   Ethylenediaminetetraacetic acid 
FPLC   Fast protein liquid chromatography 
HO   Heme oxygenase 
IPTG   Isopropyl -D-1-thiogalactopyranoside 
Isd   Iron-regulated surface determinant 
IsdG–heme  Heme-bound IsdG 
IsdG–heme–CN Cyanide-inhibited IsdG 
KPi   Potassium phosphate 
MCD   Magnetic circular dichroism 
MRSA   Methicillin-resistant Staphylococcus aureus 
NaPi   Sodium phosphate 
nCHO   Non-canonical heme oxygenase 
PMSF   Phenylmethanesulfonylfluoride fluoride 
SOC   Spin orbit coupling 
TEV   Tobacco etch virus 
UV-CD  Ultraviolet CD 
VTVH   Variable-temperature, variable-field 
WT   Wild-type  
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INTRODUCTION 
Staphylococcus aureus is one of the leading causes of healthcare-associated infection in 
the United States (US). It is highly communicable and especially life-threatening to those with 
compromised immune systems. Furthermore, drug-resistant strains of this bacterium exist, such as 
methicillin-resistant S. aureus (MRSA). MRSA has been achieving stronger resistance to 
commonly used antibiotics and is one of the leading causes of mortality in the US.1 According to 
the Centers for Disease Control and Prevention, there were over 80,000 severe cases of healthcare-
associated MRSA that resulted in over 11,000 deaths in the US in 2011.2 Additionally, the rates of 
community-associated MRSA, infection in the general population that was not contracted from 
being in a healthcare setting, have increased rapidly over the past decade.2 With this being said, 
understanding the mechanism by which S. aureus infects the human host provides information 
crucial to the design of a new drug to target and prevent this process. Designing a drug to combat 
S. aureus requires the identification of a reaction that is unique to the bacterium’s metabolism as 
a drug target. 
Iron is an essential nutrient used by S. aureus to power its pathogenesis throughout the 
eukaryotic host. The iron-containing porphyrin compound heme is the bacteria’s primary source 
of iron. Heme is found within various biological molecules in the eukaryotic host including 
hemoglobin, in which it is used to bind and transport oxygen to tissues throughout the host.3 IsdG 
has been discovered to be the primary enzyme involved in the iron acquisition pathway from heme 
by S. aureus.4 IsdG belongs to a family of nine iron-regulated surface determinant (Isd) proteins 
that are also involved in the iron acquisition and heme degradation pathway.5 A model has been 
proposed regarding the role each enzyme in the Isd family plays in the iron acquisition pathway 
by S. aureus. It is hypothesized that S. aureus first produces toxins such as hemolysins that lyse 
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red blood cells, releasing hemoglobin. IsdH and IsdB, located along the cell wall, bind free 
hemoglobin and remove heme for transfer to IsdA and IsdC (Figure 1). Heme is transported 
through the cell wall into the cytoplasm using the membrane transporter composed of IsdDEF. 
Within the cytoplasm, IsdG and IsdI, a paralog of IsdG that has a similar structure and reaction 
products, degrade heme and liberate iron.6 Being that IsdG is the main enzyme involved in iron 
acquisition, the inhibition of this enzyme would starve S. aureus of the iron that is essential to the 
bacteria’s pathogenesis, making IsdG a potentially promising drug target.4 
 
 
 
 
 
 
 
 
 
 
Figure 1. Proposed Isd heme-scavenging pathway used by S. aureus.7 The proposed pathway 
involves the binding of hemoglobin to IsdH and IsdB, which transfer heme to IsdA (PDB ID: 
2ITF), IsdC (PDB ID: 2O6P), and IsdE (PDB ID: 2Q8Q). The transporter protein complex 
IsdDEF transports heme across the cell membrane into the cytoplasm where IsdG is located. 
Figure adapted from Ref. #7.  
 
 
The eukaryotic host also contains canonical HOs that have similar enzymatic functions to 
the non-canonical HO (nCHO) IsdG and also degrade heme. To develop a new drug target that 
selectively inhibits IsdG in the presence of canonical HOs, the differences between IsdG and 
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canonical HOs must be considered. Both canonical HOs and IsdG utilize the same substrates, heme 
and molecular oxygen; however, they convert these reactants into different products through 
different reaction mechanisms. Canonical HOs catalyze the oxidative degradation of heme into 
biliverdin, a dioxygenated tetrapyrrole, carbon monoxide and free iron (Figure 2). The proposed 
mechanism of heme degradation by canonical HOs begins with the reduction of Fe(III) to Fe(II) 
by NADPH-cytochrome P450 reductase and the binding of a peroxo ligand. The resultant 
intermediate is further reduced by the reductase into a hydroperoxide heme intermediate. The 
compound self-hydroxylates at the α-meso carbon of the porphyrin ring, forming α-meso-
hydroxyheme, which undergoes additional oxidoreductive steps to form biliverdin (Figure 2). 8 
 
 
 
 
 
 
 
 
 
Figure 2. Pathway of heme degradation by canonical HOs.8 The transformation of heme 
to biliverdin is catalyzed by HO and the reaction of biliverdin into bilirubin is catalyzed by 
biliverdin reductase. Figure adapted from Ref. #8. 
 
On the other hand, nCHOs such IsdG produce staphylobilins, trioxygenated tetrapyrroles, 
formaldehyde and free iron (Figure 3). Previous studies have determined that heme degradation 
by IsdG yields staphylobilins through ferric-peroxoheme and meso-hydroxyheme intermediates. 
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However, the mechanism for the conversion between these intermediates is not well understood.9 
It has been determined that the reductase catalyzing the reactions is IruO.10 During this reaction 
the porphyrin complex is hydroxylated at the β- or δ-meso carbon, rather than at the α-meso carbon, 
as is the case with canonical HOs.11 This results in the formation of 5-oxo-δ-bilirubin or 15-oxo-
β-bilirubin, also known as staphylobilins, and formaldehyde rather than CO.12 The lack of CO 
production indicates that the IsdG reaction does not involve verdoheme, a key intermediate in the 
canonical HO heme degradation reaction that results in the production of CO. Further insight into 
the mechanism of IsdG is crucial to the development of a potential therapeutic drug target that is 
specific to IsdG and not canonical HOs.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Reaction products from heme degradation by HO, IsdG and MhuD.11 Each reaction 
pathway results in the formation of different products. Figure adapted from Ref #11. 
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Moreover, the structure of IsdG differs from that of canonical HOs.  IsdG consists of 
homodimeric β-barrel structures with two active sites that contrasts with the α-helical structure of 
canonical HOs.13 Also, various active site residues of IsdG were confirmed to be involved in the 
heme degradation reaction by studying the effect that a substitution to each residue had on the 
heme degradation rate. These included Asn7, Met38, Trp67 and His77. Asn7, Trp67, and His77 
were substituted for Alanine, which completely eliminated IsdG activity in these variants. Alanine 
substitution of Met38 resulted in a slight reduction of IsdG activity and shifted the Soret band 
absorbance from about 410 to 430 nm as a result of changes to the interaction between IsdG and 
heme resulting from the substitution.13 Substitutions of residues predicted to be outside of the 
catalytic pocket of IsdG were found to have no significant effect on IsdG activity, as was expected 
being that such residues do not form as strong of interactions with the heme substrate as the active 
site residues.13 Additionally, at least two of these second-sphere residues are known to be unique 
to the active site of IsdG and not found in human HOs, including Asn7 and Trp67.13 Similar to the 
differences in the reaction mechanisms of IsdG and canonical HOs, their structural differences also 
serve as useful information for the development of a drug target specific to IsdG. 
The structure of heme-bound IsdG (IsdG–heme) has been determined from a previous 
study generated the X-ray crystal structure of N7A IsdG–heme, the only crystal structure available 
for heme-bound IsdG.14 This structure illustrated that heme forms hydrophobic interactions with 
various residues including Leu9, Phe23, Phe64, Trp67, Leu68 and Val80. The side chain of Trp67 
forms a steric contact with the β-meso carbon in heme (Figure 4C). This interaction resulted in 
greater distortion or ruffling of the planar porphyrin ring of 2.0 Å than observed for other heme-
binding proteins, including HOs which distort it by less than 0.5 Å.14 The nonplanarity of heme 
when bound to IsdG suggests that the mechanism of heme degradation by IsdG is different from 
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that of canonical HOs. Moreover, the extent of heme ruffling has been seen to be related to the 
activity of IsdG. The W67A variant of IsdG was found to have reduced activity being that the 
substitution of Trp with Alanine eliminated the steric contact that forms between Trp and the β-
meso carbon in heme that plays a role in distorting heme.14 More specifically, heme ruffling has 
been determined to enhance the reactivity of the peroxoheme intermediate by orienting the β- or 
δ-meso carbons toward the oxygen species.14 As a result of this, heme ruffling promotes the 
formation of aldehyde by IsdG, rather than CO produced by canonical HOs.14 It has also been 
proposed that the extent of heme ruffling alters the electronic configuration of the intermediate 
species.15 Overall, the nonplanarity of the heme when bound to IsdG is one of the most unique 
features about the enzyme that distinguishes it from canonical HOs. 
 
 
 
 
Figure 4. IsdG–heme structure.14 A) Apo-IsdG (cyan) superimposed over IsdG–heme (yellow), 
B) IsdG active site viewed from the distal side, C) IsdG–heme active site with the residues that 
interact with heme. Figure adapted from Ref #14. 
 
 
This study investigates the role of the active site residue, Trp67, which has been predicted 
to be involved in binding and degrading heme. Although Trp67 is known to be required for IsdG 
activity, it’s specific role in the process is still being investigated. Trp67 has been found to form 
non-bonding interactions with the His–heme–O2 moiety. It has been hypothesized that its role may 
include positioning heme with respect to the other residues in the active site and to stabilize the 
intermediate species formed during heme oxygenation, directly contributing to the ruffling of the 
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porphyrin ring of heme.13 In this study, Trp67 was mutated into Alanine (Ala, A) and 
Phenylalanine (Phe, F), amino acids with smaller structures. The substitution of Trp to Phe was 
done in a previous study to the analogous Trp residue in IsdI. This substitution in IsdI resulted in 
reduced heme ruffling and enzymatic activity.16 Therefore, W67F IsdG was also expected to result 
in reduced heme ruffling and enzymatic activity compared to that of WT IsdG. The effects of the 
W67A and W67F substitutions on the structure and enzymatic activity of IsdG were analyzed 
using ultraviolent circular dichroism (UV CD), electronic absorption (Abs), and magnetic CD 
(MCD) spectroscopies.  
UV CD spectroscopy was used to visualize changes to the secondary structure of IsdG that 
resulted from the substitution of the active site residue. This provided information to assess 
whether any enzyme activity changes could be attributed to protein secondary structure changes. 
This technique involves shining left and right circular polarized light on a sample and a detector 
that determines the degree to which an optically active sample rotates the plane of polarized light. 
The specific CD peaks produced by the interaction of the circular polarized light with the sample 
in each spectrum correlate to the proportion of α-helices and β-sheets in the protein. A ratio of the 
two elements can be calculated from the data and used to quantify the changes in the secondary 
structure.17 Further spectroscopic analyses were carried out on variants that had significantly 
similar proportions of these secondary structure elements.  
Abs spectroscopy was used to compare the activity of WT and W67F IsdG–heme to 
determine whether the substitution reduced enzymatic activity as hypothesized. Abs spectra of 
heme-binding proteins contain a Soret peak that results from intraligand π → π* transitions. The 
presence of heme bound in a protein’s active site alters the location and shape of the Soret. 
Therefore, the changes in the Abs spectrum of the Soret band observed over time provide insight 
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into the rate of heme degradation by an enzyme in the presence of a reductant, such as ascorbate 
which is used in this study. Additionally, Abs spectroscopy was used to assess the amount of heme 
ruffling exerted by W67F IsdG. The amount of distortion of the porphyrin complex was 
determined using the PBE/TZVP TDDFT-predicted Abs spectra from a previous study involving 
a heme-bound nCHO, MhuD (Figure 5). The figure illustrates the dependence of the Q and Soret 
band energies on heme ruffling, which appear to red-shift with increased porphyrin ruffling greater 
than 1.0 Å.18  
 
 
 
 
 
 
 
 
 
 
Figure 5. PBE/TZVP TDDFT-predicted Abs spectra from the X-ray crystal structure of WT 
MhuD–heme–CN (PDB ID 4NL5).18 The model illustrates the relationship between the energy 
of the Q and Soret bands and the amount of heme ruffling in terms of b1u out-of-plane distortion. 
Figure adapted from Ref #18. 
 
Lastly, MCD spectroscopy was used to gain further information regarding electronic 
structures of WT and W67F IsdG. This technique involves the differential absorption of 
circularly polarized light in the presence of a magnetic field. The magnetic field creates a 
difference in the energy of electronic transitions in degenerate states, resulting in different types 
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of peaks that are labeled A, B, and C terms. The C term is a temperature-dependent absorption-
shaped peak that arises from the splitting of a degenerate ground state in low temperature MCD 
spectroscopy. The A and B terms are temperature-independent peaks that are derivative and 
absorption-shaped, respectively. These terms contribute very little to the peaks seen at low 
temperatures being that they are temperature independent. Obtaining MCD data at cryogenic 
temperatures is useful in determining the ground state electron configuration.19 Therefore, the 
MCD spectra of W67F and WT IsdG were compared to determine the electronic configuration of 
the Fe(III) in heme. For Abs and MCD spectroscopic analysis, cyanide was added and served as 
an analogue for the peroxo ligand that is normally involved in the heme degradation mechanism. 
CN, a π-acceptor ligand, promoted the formation of a low-spin Fe(III) complex. 
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METHODS 
Protein Expression & Purification 
The materials used in this work were purchased from Fisher Scientific and were not further 
purified, unless otherwise specified.  
Expression of IsdG. Short-linker WT was cloned into a pET15b (Ampr, Novagen) plasmid as 
previously described for long-linker WT IsdG (IBC protocol #: 12-017).4, 6, 17 S219V tobacco etch 
virus (TEV) protease was cloned into a pRK793 (Ampr) plasmid and expressed as previously 
described.17, 20 The W67A and W67F substitutions were introduced into the isdG gene encoded 
within the pET15b plasmid through site-directed mutagenesis with the QuikChange Lightning site-
directed mutagenesis kit (Agilent), as described for N7A IsdG.17 A short-linker construct was used 
in the preparation of WT and W67F IsdG, which lacked the 12 amino acid N-terminal linker 
between the TEV protease cleavage site and the start of the isdG gene, rather than the long-linker 
construct used for W67A and in previous IsdG studies.4, 6, 17 The DNA primers used to introduce 
the W67A and W67F substitutions were designed according to the guidelines in the kit and were 
purchased from the Midland Certified Reagent Company. The DNA was extracted using the 
QIAprep Spin Miniprep Kit (Qiagen). DNA sequencing at the University of Vermont Cancer 
Center DNA Analysis facility confirmed the WT sequence, the introduction of the substitutions 
and the deletion of the 12 amino acid linker. The pET15b plasmids encoding WT, W67A and 
W67F IsdG were then transformed into Escherichia coli BL21-GOLD (DE3) cells (Stratagene) 
and expressed as described for long-linker WT IsdG.6 The cells were grown at 37 °C while shaken 
at 425 rpm using a Thermo Scientific MaxQ 5000 floor-model shaker for three hours. Upon 
reaching mid-log phase, an OD600 of 0.8, the cells were induced with 1.0 mM isopropyl -D-1-
thiogalactopyranoside (IPTG). Cell growth continued for four hours at 37 °C, and then the cells 
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harvested by centrifugation at 4 °C, 10,000 x g for 10 min using a Thermo Scientific Sorvall 
Legend XT centrifuge with a FiberLite F14-6x250 LE rotor. The resultant cell pellets were stored 
at -20 °C. 
Purification of IsdG. The purification of WT and W67F IsdG followed the procedure used 
for long-linker IsdG with minor changes.6 Each cell pellet was re-suspended in 25 mL of 50 mM 
Tris pH 7.4, 150 mM NaCl, 5 mM phenylmethanesulfonylfluoride fluoride (PMSF, Pierce) and 25 
units of DNase1 (Pierce). Cells were lysed enzymatically through incubation with 0.1 mg/mL of 
lysozyme for 1 hr at room temperature. The lysate was centrifuged at 15,000 x g, 4 °C for 1 hr and 
the resulting supernatant was filtered through a 0.45 m membrane using a desktop vacuum filter 
(Millipore). The filtered lysate were loaded onto a nickel-charged HiTrap Chelating HP column 
(GE Healthcare) that was equilibrated with 50 mM Tris pH 7.4, 150 mM NaCl using an Äkta Pure 
fast protein liquid chromatography (FPLC) system (GE Healthcare). The column was washed with 
a linear gradient of imidazole from 0 to 80 mM, before the IsdG variant was eluted with 250 mM 
imidazole. A similar procedure was used to purify the TEV cell pellet.17, 20 
The N-terminal His6-tag was removed using a procedure described for IsdI, another iron-
regulated surface determinant enzyme.4, 18 Purified S219V TEV protease was added to each of the 
purified His6-tagged IsdG samples to form a solution of 10% TEV protease (v/v), 1 mM 
dithiothreitol (DTT), a reducing agent, and 0.5 mM ethylenediaminetetraacetic acid (EDTA), a 
chelating agent. The solution was concentrated and dialyzed against 1 L of 50 mM sodium 
phosphate (NaPi) pH 7.4, 300 mM NaCl for 3 hrs at 4 °C, and then again against 1 L of 50 mM 
Tris pH 7.4, 150 mM NaCl overnight at 4 °C. To remove the N-terminal His6-tag, each protein 
solution was loaded onto a HisPur Ni-NTA column equilibrated and washed with 50 mM Tris pH 
7.4, 150 mM NaCl, 20 mM imidazole. The untagged IsdG protein eventually eluted while the 
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S219V TEV protease remained adsorbed to the column. SDS-PAGE confirmed that the flow-
through consisted of untagged IsdG samples each with > 90% purity (Figure 6). 
 
 
 
 
 
 
 
 
 
Figure 6. SDS-PAGE gel of W67F IsdG Purification. (A) Pure TEV Protease, (B) Uncleaved 
W67F IsdG, (C) Cleavage reaction, (D) Cleaved purified W67F IsdG at 12.6 kDa, (E) 1/10 
dilution of cleaved W67F IsdG,  (F) 1/100 dilution of cleaved W67F IsdG, (L) PageRuler Plus 
prestained protein ladder. 
 
 
Substrate Binding 
IsdG–Heme Sample Preparation. The purified untagged WT, W67A and W67F IsdG 
samples were combined with heme as outlined in the literature for other heme-bound HO 
complexes.9 A 500 M hemin chloride solution was prepared by first dissolving 3.3 mg of hemin 
chloride in 200 L of 1.0 M NaOH, and then diluting the solution to a total volume of 10 mL with 
50 mM Tris pH 7.4, 150 mM NaCl. The solution was back-titrated to a pH of 7.4 with 150 L of 
1.0 M HCl. The IsdG proteins were each combined with the hemin solution in a 1:1 molar ratio 
and then incubated at 4 °C for 1 hr. After, each IsdG–heme solution was exchanged into 10 mM 
A         B        C        D         E        F         L 
 16 
potassium phosphate (KPi) pH 7.4 using a PD-10 desalting column (GE Healthcare), removing 
any excess hemin in solution. 
IsdG–Heme–CN Sample Preparation. To prepare cyanide-inhibited IsdG (IsdG–heme–
CN) samples, a crystal of KCN was added to a solution of 500 M hemin chloride in 50 mM Tris 
pH 7.4, 150 mM NaCl, prepared as described above, in a fume hood. The heme/CN solution and 
IsdG samples were combined in a 0.5:1 molar ratio and incubated at 4 °C for 1 hr. The resultant 
IsdG–heme–CN samples were exchanged into 10 mM KPi pH 7.4 using a PD-10 desalting column. 
 
Spectroscopic Characterization 
CD Spectroscopy. CD spectroscopy was used to compare the secondary structures of apo 
and holo forms of W67A and W67F IsdG to that of WT IsdG. Both apo and holo forms of WT, 
W67A and W67F IsdG were exchanged into 10 mM KPi pH 7.4 using PD-10 desalting columns 
and were loaded into a quartz cuvette of a 2 mm path length (Starna). Room temperature CD 
spectra were acquired from 260 to 185 nm with a scan speed of 20 nm/min, bandwidth of 1.0 nm, 
digital integration time of 8 s, and data pitch of 0.5 nm using a Jasco J-1700 Circular Dichroism 
Spectrophotometer.  
The spectra were analyzed using the Dicroweb program CDSSTR to determine the 
proportions of the secondary structures in each IsdG variant. This program calculated the 
proportions of α-helices and β-sheets which were compared between the heme and apo forms of 
W67F versus WT IsdG. Root-mean-square-deviation (RMSD) error values calculated within a 
previous study were used to estimate the systemic error for the UV CD analysis.21 No further 
spectroscopic characterization was used to analyze the W67A IsdG variant after UV CD analysis. 
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Abs Spectroscopy. The molar extinction coefficient for each sample was determined using 
the pyridine hemochrome assay, a method commonly used for heme-bound proteins in the 
literature.22  The extinction coefficients calculated from the assays include the following: 565 = 
173.07 mM-1cm-1 for W67F IsdG–heme, 418 = 133.67 mM-1cm-1 for W67F IsdG–heme–CN, and 
420.5 = 94.9 mM-1cm-1 for WT IsdG–heme–CN.  
Room temperature Abs spectra were collected for the W67F and WT IsdG–heme–CN 
samples in 50 mM Tris pH 7.4, 150 mM NaCl. Porphyrins, such as heme, have two intense bands, 
named the Q and Soret band, in the 400-600 nm region of the spectra that are commonly noted in 
the literature. The differences in energies of these peaks were used to quantify the difference in the 
amount of heme ruffling between W67F and WT IsdG–heme–CN using the QM/MM model 
described in a previous study.18 The Abs spectra were collected on a Cary 100 Bio 
spectrophotometer from 700 to 300 nm with a scan rate of 600 nm/min, bandwidth of 2 nm, digital 
integration time of 0.1 s, and data interval of 1.0 nm.  
MCD Spectroscopy. MCD spectroscopy was used to compare the electronic structures of 
W67F and WT IsdG–heme–CN. Samples of 10 M and 100 M W67F IsdG–heme–CN were 
prepared to visualize the Soret and Q bands, respectively. Each protein was first exchanged into 
125 mM KPi pH 7.4 using a PD-10 desalting column and concentrated. The protein solutions were 
combined with glycerol, to protect the sample from damage at cryogenic temperatures, and CN- to 
yield a final solution of 50 mM KPi pH 7.4, excess CN-, and 60% (v/v) glycerol. The samples were 
loaded into a custom-built oxygen-free copper/quartz cuvette of a 2 mm path length and flash 
frozen in liquid nitrogen. The samples were stored in liquid nitrogen within a Bio-CaneTM canister. 
MCD spectra and VTVH MCD saturation magnetization curves were acquired on a setup of a 
Jasco J-815 spectropolarimeter and an Oxford SM4000-8T Spectromag controlled by a Mercury 
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iTC temperature controller and Mercury iPS power supply. Cryogenic temperature spectral data 
were acquired between 800 and 300 nm for the 10 M sample and between 800 and 475 nm for 
the 100 M sample. The data were acquired as a function of magnetic field strength at 2, 5, 10, 
and 20 K with a scanning speed of 200 nm/min, bandwidth of 1 nm, digital integration time of 
0.25 s, and a data pitch of 0.5 nm.  
Igor Pro was used to analyze all CD and MCD data collected. The data in the spectra were 
converted to  units using the following calculation: Δ𝜀 =
𝑚𝑑𝑒𝑔
3298∗𝑐∗ℓ
 , in which “c” is the 
concentration of the protein in the sample and “ℓ” is the path length of the cuvette. The path length 
of the cuvette used was 0.2 cm for CD spectroscopy and 0.3 cm for MCD spectroscopy. The natural 
CD spectrum contribution was removed from all MCD data in this work by dividing by the 
difference between the positive and negative magnetic field data by two. 
 
Activity Assays 
Activity Assay Preparation. The activities of WT and W67F IsdG–heme were determined 
by reacting each protein with heme as has been done in previous studies.6, 18 The activities were 
measured in the presence of catalase and both in the absence and presence of superoxide dismutase 
(SOD). In the absence of SOD, the reaction solution was composed of 10 M of an IsdG–heme 
sample in 20 mM Tris pH 7.4, 50 mM NaCl, 0.5 L catalase, 1 mM EDTA and 1 mM sodium 
ascorbate. Due to ascorbate’s high reactivity, ascorbate was added to the reaction last. The rate of 
heme degradation by each variant was monitored by Abs spectroscopy starting immediately after 
adding the ascorbate for every 5 min for 170 min from 800 to 350 nm using a Cary 100 Bio 
spectrophotometer with a scan rate of 600 nm/min, bandwidth of 2 nm, averaging time of 0.1 s, 
and a data interval of 1 nm. The activity measured in the presence of SOD involved the same 
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reaction except that 90 units/mL of SOD were added to the solution before adding 1 mM ascorbate. 
All assays were run at room temperature. The pseudo-first-order rate constant of heme degradation 
by each species was determined by fitting the decrease in the Soret band absorbance at 412 nm to 
an exponential decay using GraphPad Prism. 
Liquid chromatography-mass spectrometry (LC-MS) was used to determine the 
composition of the products formed by the heme degradation reaction catalyzed by W67F IsdG. 
The LC-MS analysis was performed on a Shimadzu Prominence HPLC instrument coupled to an 
ABI Sciex 4000 QTrap Pro mass spectrometer operated in positive ion mode. The samples were 
loaded on a Jupiter C-18 column (150 x 1 mm; 5 μm, Phenomenex) at a flow rate of 80 μL/min.  
The following conditions were used for the W67F IsdG–heme sample with SOD: 1 min, 2%B; 1-
15 min, 98%B; 15-20 min, 98%B; 20-20.01 min, 2%B, 20.01-35 min, 2%B. Similar conditions 
were used for the W67F IsdG–heme sample without SOD: 2 min, 2%B; 2-33 min, 98%B; 33-
35.99 min, 98%B; 35.99-36 min, 2%B, 36-50 min, 2%B. For each sample, solvent A was 0.1% 
formic acid in water and solvent B was 0.1% formic acid in acetonitrile. Electrospray conditions 
in a positive ion mode with a capillary voltage 5500V at 400 ºC. W67F IsdG–heme with SOD was 
analyzed in the Q1 scanning mode at a scan speed of 250 m/Z sec over a range of 250 to 1000 
m/Z. W67F IsdG–heme without SOD was analyzed in the Q3, linear ion trap, scanning mode at a 
scan speed of 1000 m/Z sec over a range of 250 to 1000 m/Z with a collision energy fixed at 5 V. 
The Q3 scanning mode was used instead of the Q1 scanning mode to improve the resolution of the 
peaks in the chromatogram of the sample of W67F IsdG–heme without SOD. This was not 
necessary for the sample of W67F IsdG–heme with SOD. 
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RESULTS 
Activity Assays 
CD Assays. UV CD spectroscopy was used to gain insight into changes to the secondary 
structure of IsdG as a result of the W67A and W67F substitutions. These data provided an 
assessment of whether any enzyme activity changes could be attributed to protein secondary 
structure changes. UV CD data were collected and compared between WT and W67A IsdG (Figure 
7) and between WT and W67F IsdG–heme (Figure 8). The spectra were analyzed using the 
CDSSTR program by Dicroweb. The algorithm used by this program quantified the proportions 
of α-helices and β-sheets in each variant of IsdG. The CDSSTR program fit the experimental and 
reconstructed data better than any other program by Dicroweb.  
The W67A and WT IsdG spectra in Figure 7 were significantly different in shape, 
especially compared to that of W67F and WT IsdG–heme in Figure 8. This indicated that there 
were significant differences between the secondary structures of WT and W67A IsdG, so it would 
be impossible to distinguish whether any changes in activity of W67A IsdG are the result of the 
differences in the enzymes’ secondary structure or of second-sphere interactions within the 
enzyme active site. Therefore, no further spectroscopic analysis was conducted on W67A IsdG. 
 On the other hand, the WT and W67F IsdG–heme spectra were very similar in shape, with 
slightly more intense peaks observed in the W67F IsdG–heme spectrum. The ratio of these 
secondary structural elements calculated by CDSSTR were compared to quantify the similarity of 
two proteins’ secondary structures. W67F IsdG–heme contained 2% more α-helices and 1% less 
β-sheets than WT IsdG–heme. Apo W67F IsdG contained 2% less α-helices and 3% more β-sheets 
than apo WT IsdG. Each of these differences were below the range of RMSD values of 0.065 to 
0.070, which were determined for this program in a previous study.21 This indicated that there 
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were no significant differences between the secondary structures of WT and W67F IsdG–heme, 
so any changes to the activity observed by W67F IsdG were attributed to changes in second-sphere 
interactions within the enzyme active site. 
 
 
 
 
 
 
 
 
Figure 7. UV CD spectra of Apo W67A (red) and WT (blue) IsdG in 10 mM KPi  pH 7.4. The 
significantly different spectra indicate that there were significant changes to the secondary 
structure of IsdG as a result of the amino acid substitution. 
 
 
 
 
 
 
 
 
 
Figure 8. UV CD spectra of W67F (red) and WT (blue) IsdG–heme in 10 mM KPi  pH 7.4. 
Through analysis of the spectra with CDSSTR, it was determined that there were no significant 
changes to the secondary structure of IsdG, despite the amino acid substitution. 
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Abs Assays. While the activity of W67F IsdG had not been previously studied, the W67A 
variant resulted in a loss of activity in a previous study.14 Likewise, the W66F variant of IsdI, 
which involved the same substitution to IsdI’s analogous Trp residue, resulted in reduced enzyme 
activity.16 Thus, it was hypothesized that the substitution of the Trp residue in IsdG to a smaller 
residue, Phe, would result in reduced enzyme activity as well. To test this, ascorbate-catalyzed 
degradation of heme was monitored spectrophotometrically every 5 min for 170 min. Catalase was 
added to all solutions at the start of the reaction to eliminate the possibility for any free hydrogen 
peroxide in the solution to cause heme degradation.23 The Soret band at 412 nm, representing the 
IsdG protein bound to heme in a 1:1 heme to protein ratio, shows a clear decrease over the entire 
period in both the WT (Figure 9) and W67F IsdG–heme (Figure 10) spectra. This indicates that 
the enzyme is still active, despite the substitution of the active site residue. There was also a small 
peak that increased overtime at approximately 680 nm in the W67F IsdG spectra in the absence of 
SOD, which has been cited to be consistent with biliverdin formation (Figure 10).6  
Activity assays were done in both in the presence and absence of SOD, an enzyme that 
catalyzes the dismutation of any superoxide radicals into hydrogen peroxide and molecular 
oxygen. Any hydrogen peroxide produced in this process is decomposed by catalase into water 
and oxygen to prevent it from causing oxidative damage. The addition of SOD did not appear to 
alter the shape of the WT spectra (Figure 9), while it did alter the shape of the W67F IsdG–heme 
spectra (Figure 10). The W67F spectra in the presence of SOD, on the right of Figure 10, contained 
less intense peaks at longer wavelengths after the Soret peak at 412 nm through 500 nm, illustrating 
a clearer conversion of IsdG–heme into products.  
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Figure 9. Abs activity data for the reaction of WT IsdG–heme with ascorbate. The assay 
consisted of 10 μM WT IsdG–heme in 20 mM Tris pH 7.4, 50 mM NaCl, 1 mM ascorbate, 1 
mM EDTA and 0.5 L catalase. For the reaction in the presence of SOD, 0.03 mg SOD was 
added to the solution. Spectra were taken every 5 min for 170 min. Both spectra also show a 
reduction of the IsdG–heme Soret band at ~412 nm over time, indicating that WT IsdG is active. 
 
 
 
 
 
 
 
 
 
 
Figure 10. Abs activity data for the reaction of W67F IsdG–heme with ascorbate. The assay 
consisted of 10 μM W67F IsdG–heme in 20 mM Tris pH 7.4, 50 mM NaCl, 1 mM ascorbate, 1 
mM EDTA and 0.5 L catalase. For the reaction in the presence of SOD, 0.03 mg SOD was 
added to the solution. Spectra were taken every 5 min for 170 min. Both spectra show a 
reduction of the IsdG–heme Soret band at ~412 nm and a decreasing Q band at ~530 nm over 
time, suggesting that W67F IsdG–heme is active. 
W67F IsdG–heme W67F IsdG–heme with SOD 
 
WT IsdG–heme WT IsdG–heme with SOD 
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From the activity assay data, the rate constants of WT and W67F IsdG-catalyzed heme 
degradation in the presence and absence of SOD were calculated to better compare the relative 
activities of each enzyme.  The pseudo-first-order rate constants for WT and W67F in the presence 
of SOD were 0.0369 ± 0.0019 and 0.0166 ± 0.0046 min-1, respectively. The rate constants for WT 
and W67F in the absence of SOD were 0.0414 ± 0.0036 and 0.0399 ± 0.0088 min-1, respectively. 
In both cases the rate constant of W67F IsdG was smaller than that of WT IsdG. Additionally, the 
rate constants of both WT and W67F IsdG decreased upon the addition of SOD. The rate constant 
of W67F IsdG in the absence of SOD was greater than double the rate constant of W67F IsdG in 
the presence of SOD. This suggested that a non-enzymatic reaction is predominant in the absence 
of SOD. 
 
 
 
 
 
 
 
 
Figure 11. IsdG-catalyzed heme degradation assays fit to first order rate laws. The pseudo-first-
order rate constants for WT and W67F IsdG in the presence of SOD were determined to be 
0.0369 ± 0.0019 and 0.0166 ± 0.0046 min-1, respectively. The rate constants for WT and W67F 
in the absence of SOD were 0.0414 ± 0.0036 and 0.0399 ± 0.0088 min-1, respectively. 
 
 
The W67F samples containing catalase in the absence and presence of SOD were analyzed 
using LC-MS in positive ESI (Figure 12). Each chromatogram contained a peak at m/Z of about 
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12,700 that represented the protein (MW 12,700 Da), a peak at m/Z of about 616 that represented 
heme (MW 616 Da) (Figure 12B,D) and at m/Z of about 583 that represented biliverdin (MW 582 
Da) (Figure 12A,C). The intensity of the peak representing biliverdin in the chromatogram of the 
W67F IsdG–heme in the presence of SOD (Figure 12C) was much smaller than that in the absence 
of SOD (Figure 12A), suggesting that much less biliverdin was produced by W67F IsdG in the 
presence of SOD. The heme degradation reaction by W67F IsdG did not appear to produce any 
bilirubin (MW 584 Da) or staphylobilin (MW 598 Da), evident by the lack of peaks corresponding 
to these compounds in the chromatograms.  
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Figure 12. ESI LC-MS of W67F IsdG–heme degradation assay products in the absence (A, B) 
and presence of SOD (C, D). A) Protonated molecular ion of biliverdin with MW 582 Da, B) 
Charged molecular ion of heme with MW 616 Da, C) Protonated molecular ion of biliverdin in 
presence of SOD, D) Charged molecular ion of heme in presence of SOD. No bilirubin, MW 584 
Da, or staphylobilin, MW 598, was detected. 
 
Abs Spectroscopy 
Abs Data. Abs data were collected and compared between WT and W67F IsdG–heme–
CN to understand how the W67F substitution affected the extent of porphyrin ruffling by IsdG. 
The effect was determined by comparing the energies of the Q and Soret bands in the two spectra 
produced by UV-Vis analysis. The W67F IsdG–heme–CN Q and Soret bands each blue-shifted to 
higher energy by about 100 cm-1. The Q band shifted to 18,100 cm-1 from 18,000 cm-1 in WT IsdG 
and the Soret band shifted to 23,900 cm-1 from 23,800 cm-1 in WT IsdG (Figure 13). 
A 
B 
RT 20.7 min RT 24.08 min 
C 
D 
RT 15.33 min 
RT 14.4 min 
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The energy values of the Q and Soret bands were analyzed using the PBE/TZVP TDDFT-
predicted Abs spectra from a previous study of cyanide- and imidazole-ligated low-spin ferric 
heme.18 Figure 5 illustrates the dependence of the Q and Soret band energies on heme ruffling. 
The general trend predicted by this model is that at small distortions, increased ruffling triggers no 
change to the Q band and a blue-shift of the Soret. At larger distortions, increased ruffling triggers 
red-shifts of both the Q and Soret bands. A previous study determined that WT IsdG–heme–CN 
results in 2.04 Å of ruffling based on QM/MM calculations.24 This model indicates that because 
the Q and Soret band both blue-shift with the same magnitude, the W67F IsdG–heme–CN results 
in greater than 1.0 Å of ruffling. The fact that both the Q and Soret band of W67F IsdG–heme–
CN blue-shift from that of the WT IsdG–heme–CN indicates reduced heme ruffling in this variant. 
Based on the analysis within the study that proposed this model, it is estimated that W67F IsdG–
heme–CN results in 1.7 Å of ruffling.18 This data supported the original hypothesis that the 
substitution of Trp67 by a smaller residue would result in reduced porphyrin ruffling. 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Abs spectra of WT (blue) and W67F (red) IsdG–heme–CN in 150 mM NaCl, 50 mM 
Tris pH 7.4. The W67F Q and Soret bands each blue-shift 100 cm-1, to higher energy with 
decreased steric bulk at residue 67, indicating reduced porphyrin ruffling. 
 
 28 
MCD Spectroscopy 
MCD Data. MCD spectroscopy was used to investigate differences between the electronic 
structures of W67F and WT IsdG–heme–CN. MCD data was collected on W67F and WT IsdG–
heme–CN at higher (Figure 14) and lower energies (Figure 15), both of which provided insight 
into heme electronic structure. The data collected at lower energies were acquired using samples 
of higher concentrations of W67F and WT IsdG–heme–CN for better visualization of the weaker 
Q bands. The shapes and locations of the Soret (Figure 14) and Q bands (Figure 15) were compared 
between each spectrum. Overall, the two spectra were very different and the W67F IsdG–heme–
CN spectrum contained more intense peaks than the WT IsdG–heme–CN spectrum. The most 
intense spectral feature is the negative component of the Soret band in the W67F IsdG–heme–CN 
spectrum (Figure 13). The negative Soret peak blue-shifted by about 100 cm-1 in the W67F IsdG–
heme–CN spectrum from 23,500 cm-1 in the WT IsdG–heme–CN spectrum to 23,600 cm-1, which  
is consistent with the shift seen in the Abs spectra for WT and W67F IsdG–heme–CN (Figure 13). 
The two spectra have the same zero-crossing point for the Soret band of about 24,200 cm-1. The 
low energy region in the W67F IsdG–heme–CN spectra has similar peaks to the WT spectra.  WT 
IsdG–heme–CN had four positively signed bands at 16,800, 18,200, 19,700, and 21,700 cm-1 and 
a negatively signed band at 17,600 cm-1. W67F IsdG–heme–CN had three positively signed bands 
at 16,700, 19,700 and 21,800 cm-1 and two negatively signed bands at 17,600 and 18,400 cm-1 
(Figure 15). While most of these peaks were more intense in the W67F IsdG–heme–CN spectrum, 
the peak on the W67F spectrum at around 18,000 cm-1 was much less intense than the peak in that 
location on the WT spectrum. Overall, the introduction of the W67F substitution did not cause any 
bands to shift by more than 100 cm-1 for IsdG–heme–CN (Figures 14-15). However, the 
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differences in intensities suggest that the electronic structures of W67F and WT IsdG–heme–CN 
are different. 
The significant increase in the intensity of the negatively-signed Soret band in the W67F 
IsdG–heme–CN spectrum observed in Figure 14 is the most apparent change in the spectra. This 
observation is consistent with an increased population of the 2Eg electronic state in W67F IsdG 
seen in MCD data from other heme-binding enzymes.17-18  The intensity of the C-term of the 2Eg 
electronic state can increase as a result of spin-orbit coupling (SOC) between the two components 
of the 2Eg electronic state.18  
 
 
 
 
 
 
 
 
 
 
Figure 14. MCD spectra of 10 μM WT and W67F IsdG–heme-CN in 50 μM KPi pH 7.4, 60% 
(v/v) glycerol at 7 T, 5 K. The MCD spectrum of W67F IsdG–heme–CN is significantly different 
from that of WT IsdG–heme–CN, confirming that the electronic structure has been altered by the 
substitution. The W67F spectra contains more intense peaks than the WT spectra and the 
negative component of the Soret in the W67F spectra is significantly increased consistent with a 
transition from 2B2g to 2Eg ground state. 
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Figure 15. Low energy MCD spectra of 100 μM WT and W67F IsdG–heme-CN in 50 μM KPi 
pH 7.4, 60% (v/v) glycerol at 7 T, 5 K. The intensities of the peaks are different between the two 
spectra, but the peaks do appear at similar energies. 
 
DISCUSSION 
Abs, UV CD and MCD spectroscopy together provided insight into the influence of Trp67 
on the geometric and electronic structure of the IsdG protein. Previous studies have shown that 
active site residues of nCHOs, such as IsdG, are involved in heme ruffling and affect the electronic 
structure and reactivity of the heme complex.15-18 This investigation gained insight into the 
contribution of Trp67 on heme ruffling, which has been seen to directly contribute to heme ruffling 
as a result of the steric contact it forms with the β-meso carbon in heme (Figure 4C).14 As 
previously mentioned, heme ruffling is one of the most striking differences between the heme 
degradation reactions by IsdG and canonical HOs. Therefore, it was expected that the substitution 
of Trp67 with smaller residues, Ala and Phe, would result in reduced heme ruffling and IsdG 
activity. 
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Geometric Structure Changes to W67F IsdG 
The CD spectra of WT and W67A IsdG were significantly different, indicating that the two 
enzymes had significantly different geometric structures (Figure 7). These differences make it 
impossible to conclude whether changes in enzyme activity were the result of the change to 
second-sphere interactions. This was because such changes could also be the result of the different 
protein secondary structures. Therefore, further analysis was not conducted on W67A IsdG, and 
instead the investigation focused on W67F IsdG. 
The similarities between the WT and W67F IsdG–heme CD spectra indicated that the two 
enzymes had significantly similar geometric structures. Therefore, any changes in enzyme activity 
were concluded to be the result of second-sphere interactions (Figure 8). More specifically, any 
changes in enzyme activity were attributed to the substitution of Trp67 with Phe. The rate constants 
calculated from the activity assays of W67F IsdG were found to be smaller than those of WT IsdG, 
indicating that W67F IsdG had reduced activity compared to WT IsdG, as was hypothesized.  
Each assay of WT and W67F IsdG included a decreasing Soret band at 412 nm, which was 
indicative of a decreasing concentration of the IsdG–heme complex. In previous studies, activity 
assays of WT IsdG under similar conditions showed the peak at 412 nm disappearing into a flat 
line at the final time point, indicating that all IsdG–heme had reacted.6 However, this experiment 
did not show the same result over the course of 170 min. Instead, there appeared to be IsdG–heme 
remaining in solution, evident by the remaining peak at 412 nm (Figure 9). This could have been 
the result of the reaction using up all of the dissolved O2, one of the main reactants required for the 
heme degradation reaction.  Another explanation for this difference could have been due to the 
fact that the assays were carried out at room temperature, rather than at a higher temperature as 
was done by other studies.6, 18 A higher temperature would have been expected to accelerate the 
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reaction in which WT IsdG–heme assays would go to completion at a faster rate than the W67F 
IsdG–heme reaction would. This finding would have confirmed that the W67F IsdG enzyme had 
reduced activity compared to that of WT IsdG, as the results from this investigation suggest. 
Moreover, the presence of SOD in the WT IsdG–heme assay (Figure 9) did not 
significantly change the shape of spectra as it had in the W67F IsdG–heme assay (Figure 10). In 
the absence of SOD, peaks at about 450 and 680 nm increased in intensity over time in the W67F 
IsdG–heme assay. However, in the presence of SOD these peaks were hardly present (Figure 10). 
The rate constant calculated for the reaction of W67F IsdG was significantly smaller when in the 
presence of SOD (Figure 11). SOD is known to react with superoxide to prevent oxidative damage 
to the cell. Therefore, this finding suggested that there was a non-enzymatic reaction involving 
superoxide taking place in the absence of SOD. Thus, disrupting heme ruffling through the 
substitution of Trp67 had resulted in the production of a toxic reactive oxygen species, superoxide, 
which would have a toxic effect on the cells of S. aureus. 
Another significant finding from the activity assays was the presence of a peak on the 
W67F IsdG spectra at 680 nm. A peak at 680 nm has been noted in previous studies to be indicative 
of the presence biliverdin, the product of heme degradation by canonical HOs.6 The presence of 
biliverdin was confirmed with LCMS, which was used to compare the identity and amounts of 
products resulting from the degradation assays of W67F IsdG–heme in the presence and absence 
of SOD. Peaks representing heme (Figure 12B,D) and biliverdin (Figure 12A,C) were identified 
products of the W67F IsdG–heme assay both with and without SOD. However, the peak 
representing biliverdin was much less intense in the chromatogram of the assay in the presence of 
SOD (Figure 12C). This indicated that less biliverdin was formed by the reaction and less heme 
was degraded by W67F IsdG in the presence of SOD. This finding was consistent with the results 
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of the activity assay, in which the rate constant of W67F IsdG decreased as a result of the addition 
of SOD.  
Moreover, biliverdin was an unusual product of this reaction and has not been noted to be 
produced by other variants of IsdG. Biliverdin is the known primary product produced through 
heme degradation by canonical HOs. Staphylobilin is the known primary product of heme 
degradation by IsdG, however, this product was not detected in the assay solution.11 This suggested 
that the reaction catalyzed by W67F IsdG–heme proceeded through a unique reaction mechanism 
that differed from that of WT IsdG–heme, resulting in the production of biliverdin rather than 
staphylobilin. A similar result was found in a study involving the R26S variant of MhuD. MhuD, 
the heme degrading enzyme used by Mycobacterium tuberculosis, degrades heme into mycobilin 
and iron. However, the R26S variant of MhuD degraded heme into biliverdin instead.25 For future 
studies, it would be worthwhile to determine if the substitution of the analogous Trp residues to 
Phe in MhuD and IsdI, other nCHOs, also yields biliverdin. Overall, this finding provided further 
insight into the role of Trp67 in the heme degradation mechanism of IsdG. 
Further, Abs data collected on WT and W67F IsdG–heme–CN indicated reduced heme 
ruffling by W67F IsdG. Being that heme ruffling is important for IsdG activity, the results from 
the Abs data are consistent with the reduced activity of W67F IsdG from the W67F IsdG–heme 
observed from the activity assays. This finding also confirms that Trp67 is directly involved in 
heme ruffling as a result of the steric interaction it forms with the β- or  δ-meso carbon within heme 
to push them out of the heme plane and toward the oxygen binding site.14  
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Electronic Structure Changes to W67F IsdG 
The MCD data collected provided additional information to that collected by Abs 
spectroscopy regarding the electronic structure differences between WT and W67F IsdG–heme–
CN. The blue-shift observed for the Soret band in the Abs spectrum of W67F IsdG–heme–CN 
(Figure 13) was consistent with the shift observed in MCD spectrum for this species compared to 
that of WT IsdG–heme–CN (Figure 14). The most striking difference between the two MCD 
spectra was the increased intensity of the negatively-signed Soret band of the W67F IsdG–heme–
CN spectrum (Figure 14). This suggested that W67F IsdG–heme–CN that has a 2Eg electronic 
ground state that has a (dxy)2 (dxz, dyz)3 electron configuration (Figure 16). This differs from the 2B2g 
electronic ground state reported for WT IsdG–heme–CN that has a (dxz, dyz)4 (dxy)1 electron 
configuration (Figure 17).17-18  The symmetry between the dxz and dyz orbitals in the 2Eg state allows 
the orbitals to rotate into each other resulting in increased spin orbit coupling (SOC), enabling 
degenerate states to have different energies in the presence of a magnetic field. The SOC observed 
between the two components of the 2Eg state increased the intensity of the C-term in the MCD 
spectrum, resulting in the increased intensity observed for the negative Soret band of the W67F 
IsdG–heme–CN (Figure 14). On the other hand, the 2B2g state of WT IsdG–heme–CN lacked the 
unpaired electron in the dxz and dyz orbitals (Figure 17) that contributes to the C-term intensity, and 
therefore, the Soret peak is significantly less intense in the WT IsdG–heme–CN spectrum (Figure 
14).  
In the 2Eg ground state an unpaired electron is located in the dxz and dyz orbitals (Figure 16), 
whereas in the B2g ground state the unpaired electron is located in the dxy orbital (Figure 17). The 
reduced heme ruffling observed by W67F IsdG–heme–CN has been seen to trigger the electronic 
change from the 2B2g state to the 2Eg state. The reduced amount of heme ruffling reduces the 
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amount of unpaired electron density on the meso carbons of heme. This was consistent with the 
electron configuration in the 2Eg state in which the unpaired electron is located in the degenerate 
dxz and dyz orbitals. On the other hand, the increased amount of heme ruffling by WT IsdG–heme–
CN results in greater unpaired electron density placed on the meso carbons of heme. This was 
consistent with the electron configuration in the 2B2g state in which the unpaired electron is in the 
dxy orbital. Greater ruffling facilitates the self-hydroxylation of heme that is involved in the 
mechanism of heme degradation by WT IsdG.26 However, as previously stated, in the 2Eg ground 
state the unpaired electron is located in the degenerate dxz and dyz orbitals rather than in the dxy 
orbital. As a result, less of the unpaired electron density is placed on the meso carbons of heme 
and less heme ruffling is observed in the W67F IsdG–heme–CN complex. The 2Eg ground state 
has been observed for canonical HOs, which also exert less heme ruffling compared to WT IsdG.18 
 
 
 
 
 
 
Figure 16. MO Diagram of the 2Eg electron configuration of W67F IsdG–heme based on the 
MCD data. The intense negative Soret band in the MCD spectra results from significant SOC 
between the dxz and dyz orbitals that does not occur in the 2B2g state. 
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Figure 17. MO Diagram of the 2B2g electron configuration of WT IsdG–heme as reported by 
previous studies.14-15 There is less SOC between dxy and the other orbitals resulting in the 
reduced MCD intensity compared to that of the 2Eg state. 
 
 
A previous study used MCD spectroscopy to analyze the electronic structure of WT and 
W66F MhuD, which involved the same substitution to the analogous Trp residue in MhuD. The  
MCD spectra of W67F IsdG–heme–CN (Figures 14-15), WT MhuD–heme–CN and W66F 
MhuD–heme–CN at 5 K, 7 T (Figure 18) had similar shapes. The shapes and intensities of the 
peaks within the W67F IsdG–heme–CN and WT MhuD–heme–CN spectra were most similar.18 
At lower energy, both the WT and W66F MhuD–heme–CN spectra contained a negatively signed 
band followed by three positively signed bands. The energies of the bands differed slightly 
between the two proteins. The positive bands in the WT MhuD–heme–CN spectrum were at about 
18,600, 19,500 and 22,000 cm-1 and those in the W66F MhuD–heme–CN spectrum were at 18,300, 
19,500 and 21,599 cm-1 (Figure 18). The W67F IsdG–heme–CN spectrum was slightly different 
in that there was a negatively signed band followed by only two positively signed bands at 19,700 
and 21,800 cm-1 (Figure 15). These positively signed bands appeared at slightly higher energies 
with a blue-shift of about 200 cm-1, compared to those in the W66F MhuD–heme–CN spectrum. 
Moreover, the negative component of the Soret band was also the most intense spectral feature of 
the WT and W66F MhuD–heme–CN spectra as it was in the W67F IsdG–heme–CN spectrum. 
However, the energy of the negative Soret band in the WT MhuD–heme–CN spectrum at about 
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23,500 cm-1 was more similar to that of the negative Soret band in the W67F IsdG–heme–CN 
spectrum at about 23,600 cm-1. The differences observed between the Q and Soret bands in the 
WT and W66F MhuD–heme–CN spectra by this previous study were attributed to a transition 
from the 2B2g state to a 2Eg state, which was consistent with the findings regarding WT and W67F 
IsdG–heme–CN.18 
 
 
 
 
  
 
 
 
 
Figure 18. MCD spectra of WT (solid line), W66F (dotted line), and W66A (dashed line) 
MhuD–heme–CN at 280 (top) and 5 K (bottom), 7 T in 50 mM KPi pH 7.4, 50 mM NaCl, 60% 
(v/v) glycerol. The features of the WT MhuD spectrum are similar to those of the W67F IsdG–
heme–CN spectrum observed in Figures 14-15. Adapted from Ref #18. 
 
 
 Similarly, MCD spectroscopy was used to analyze the electronic structure of WT IsdI–
heme–CN at 5 K, 7 T (Figure 19B).27 This spectrum was similar to that of WT IsdG–heme–CN, 
which has a very similar active site structure (Figures 14-15). The study on WT IsdI–heme–CN 
concluded that the MCD data strongly suggested a 2B2g state, as was the case for the data 
collected on WT IsdG–heme–CN and WT MhuD–heme–CN.18  
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Figure 19. MCD spectra of WT MhuD–heme–CN (A, solid black), F23A MhuD–heme–CN (A, 
dotted blue), F23W MhuD–heme–CN (A, dashed red), and WT IsdI–heme–CN (B, solid black) 
at 5 K , 7 T in 50 mM KPi pH 7.4, 50 mM NaCl, 60% (v/v) glycerol. The features of the WT IsdI 
spectrum are similar to those of the WT IsdG–heme–CN spectrum observed in Figures 14-15. 
Adapted from Ref #27. 
 
 
Implications for the Design of a Small Molecule Inhibitor 
 
This study provides further insight into the interaction between Trp67 and the heme 
porphyrin complex, information that is useful for the development of a new drug target to prevent 
the degradation of heme by IsdG. As previously mentioned, IsdG degrades heme to acquire iron 
which serves as an essential nutrient used to power the pathogenesis of S. aureus. Therefore, 
preventing the acquisition of iron from heme by IsdG would inhibit the bacterium’s pathogenesis 
throughout the human host as a whole. A previous study found that IsdG binds heme with a very 
small dissociation constant, suggesting that the development of a competitive inhibitor to prevent 
their interaction would be less effective than the development of an uncompetitive inhibitor that 
binds to the enzyme-substrate complex to inhibit the interaction between Trp67 and heme.4 The 
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nitrogen within the indole ring of Trp67 faces away from heme and toward a nitrogen within the 
backbone amide bond of Phe73 (Figure 20). Phe73 is further away from heme and does not form 
contacts to the substrate as Trp67 does. A small molecule containing hydrogen acceptor atoms, 
such as a carboxylic acid group, could form hydrogen bonds to the hydrogen bonded to the nitrogen 
atoms of both Trp67 and Phe73, due to their proximity to one another. Such an interaction would 
pull the indole ring of Trp67 away from heme up toward Phe73, disrupting the steric interactions 
that Trp67 forms with the substrate. Being that Trp67 has been shown to influence heme ruffling 
and the IsdG activity, disrupting its interaction with heme would thus inhibit the extent of heme 
ruffling and IsdG activity. Additionally, the disruption of the interaction was also seen to result in 
the production of a toxic reactive oxygen species, superoxide. Such findings indicate that Trp67 
would serve as a useful drug target for inhibiting heme degradation by IsdG, required for the 
survival of S. aureus in a human host. 
 
 
 
 
 
 
 
 
Figure 20. Location of Trp67 and Phe73 in the X-ray crystal structure of N7A IsdG–heme (PDB 
ID 2ZDO).14 Trp67 forms a steric contact with heme contributing to heme ruffling. A potential 
uncompetitive inhibitor to this interaction could be a small molecule that forms hydrogen bonds 
to the Phe73 nitrogen in the amide bond and the Trp67 nitrogen within the indole ring, pulling 
the Trp67 indole ring away from heme (gray) and toward Phe73.  
 
Trp67 
Val72 
Phe73 
His77 
Val80 
Phe23 
Ala7 
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Conclusion 
Overall, the findings from this investigation support the original hypothesis that the W67F 
substitution resulted in reduced enzymatic turnover and heme ruffling compared to WT IsdG. 
Thus, Trp67 has been confirmed to be involved in heme ruffling and enzymatic turnover by IsdG. 
Spectroscopic characterizations of WT and W67F IsdG–heme–CN have indicated that the second-
sphere Phe residue does not introduce a geometric change to the IsdG enzyme, but does alter the 
electronic structure of the IsdG–heme complex. A significant finding of this study was that heme 
degradation assays of W67F IsdG–heme in the presence of ascorbate and catalase resulted in the 
formation of biliverdin, the product of the heme degradation reaction by canonical HOs, rather 
than staphylobilins, the product of the reaction by WT IsdG–heme. This suggested that the reaction 
catalyzed by W67F IsdG proceeded through a different reaction mechanism than that of WT IsdG, 
indicating that Trp67 plays a significant role in the heme degradation mechanism of IsdG. 
Together, the results of this spectroscopic investigation of IsdG provide further insight into the 
unique mechanism of heme degradation by IsdG and its differences from that of canonical HOs. 
Such information is highly useful for the development of a new therapeutic drug target specific to 
IsdG and its interaction with heme. A disruption to this interaction would inhibit the ability of IsdG 
to acquire iron from heme that is necessary for the pathogenesis of S. aureus, thus preventing 
further infection of the eukaryotic host by the bacterium. 
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Supporting Information 
 
Table S1. Long linker W67A primer 
 
Primer   Sequence 
Forward 5'-TGCTTTAAAGACATCAGATTTTAACGCATCCGTAAAAGCTTGCTTTGATTTC-3' 
Backward 5'-GAAATCAAAGCAAGCTTTTACGGATGCGTTAAAATCTGATGTCTTTAAAGCA-3' 
 
Table S2. Long linker W67F primer 
 
Primer   Sequence 
Forward 5'-GCTGCTTTAAAGACATCAGATTTTAAGAAATCCGTAAAAGCTTGCTTTG-3' 
Backward 5'-CAAAGCAAGCTTTTACGGATTTCTTAAAATCTGATGTCTTTAAAGCAGC-3' 
 
Table S3. W67A IsdG Gene Sequence including N-terminal His6-tag, long-linker, and TEV 
cleavage site. The polypeptide begins at S-1, after the S219V TEV cleavage. 
 
M-32 G-31 H-30 H-29 H-28 H-27 H-26 H-25 D-24 Y-23 
ATG GGT CAT CAT CAT CAT CAT CAC GAT TAC 
D-22 I-21 P-20 T-19 T-18 E-17 N-16 L-15 Y-14 F-13 
GAT ATC CCA ACG ACC GAA AAC CTG TAT TTT 
Q-12 G-11 A-10 H-9 M-8 G-7 I-6 Q-5 R-4 P-3 
CAG GGC GCC CAT ATG GGA ATT CAA AGG CCT 
T-2 S-1 T0 M1 K2 F3 M4 A5 E6 N7 
CAG TCG ACC ATG AAA TTT ATG GCA GAA AAT 
R8 L9 T10 L11 T12 K13 G14 T15 A16 K17 
AGG CTG ACG TTA ACA AAA GGA ACA GCA AAA 
D18 I19 I20 E21 R22 F23 Y24 T25 R26 H27 
GAT ATT ATA GAA CGA TTT TAG ACG AGA CAT 
G28 I29 E30 T31 L32 E33 G34 F35 D36 G37 
GGG ATT GAA ACA TTA GAA GGC TTT GAT GGC 
M38 F39 V40 T41 Q42 T43 L44 E45 Q46 E47 
ATG TTT GTT ACA CAA ACT TTA GAA CAA GAA 
D48 F49 D50 E51 V52 K53 I54 L55 T56 V57 
GAT TTT GAT GAA GTG AAA ATT TTA ACA GTT 
W58 K59 S60 K61 Q62 A63 F64 T65 D66 A67 
TGG AAA TCA AAG CAA GCT TTT ACG GAT GCG 
L68 K69 S70 D71 V72 F73 K74 A75 A76 H77 
TTA AAA TCT GAT GTC TTT AAA GCA GCG CAT 
K78 H79 V80 R81 S82 K83 N84 E85 D86 E87 
AAA CAT GTT AGA AGT AAA AAT GAA GAT GAA 
S88 S89 P90 I91 I92 N93 N94 K95 V96 I97 
AGT AGC CCG ATT ATA AAT AAC AAA GTA ATT 
T98 Y99 D100 I101 G102 Y103 S104 Y105 M106 K107 
ACA TAT GAT ATA GGC TAT AGT TAC ATG AAA 
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Table S4. W67F IsdG Gene Sequence including N-terminal His6-tag, short-linker, and TEV 
cleavage site. The polypeptide begins at S-1, after the S219V TEV cleavage. 
 
M-22 G-21 H-20 H-19 H-18 H-17 H-16 H-15 D-14 Y-13 
ATG GGT CAT CAT CAT CAT CAT CAC GAT TAC 
D-12 I-11 P-10 T-9 T-8 E-7 N-6 L-5 Y-4 F-3 
GAT ATC CCA ACG ACC GAA AAC CTG TAT TTT 
Q-2 S-1 T0 M1 K2 F3 M4 A5 E6 N7 
CAG TCG ACC ATG AAA TTT ATG GCA GAA AAT 
R8 L9 T10 L11 T12 K13 G14 T15 A16 K17 
AGG CTG ACG TTA ACA AAA GGA ACA GCA AAA 
D18 I19 I20 E21 R22 F23 Y24 T25 R26 H27 
GAT ATT ATA GAA CGA TTT TAG ACG AGA CAT 
G28 I29 E30 T31 L32 E33 G34 F35 D36 G37 
GGG ATT GAA ACA TTA GAA GGC TTT GAT GGC 
M38 F39 V40 T41 Q42 T43 L44 E45 Q46 E47 
ATG TTT GTT ACA CAA ACT TTA GAA CAA GAA 
D48 F49 D50 E51 V52 K53 I54 L55 T56 V57 
GAT TTT GAT GAA GTG AAA ATT TTA ACA GTT 
W58 K59 S60 K61 Q62 A63 F64 T65 D66 F67 
TGG AAA TCA AAG CAA GCT TTT ACG GAT TTC 
L68 K69 S70 D71 V72 F73 K74 A75 A76 H77 
TTA AAA TCT GAT GTC TTT AAA GCA GCG CAT 
K78 H79 V80 R81 S82 K83 N84 E85 D86 E87 
AAA CAT GTT AGA AGT AAA AAT GAA GAT GAA 
S88 S89 P90 I91 I92 N93 N94 K95 V96 I97 
AGT AGC CCG ATT ATA AAT AAC AAA GTA ATT 
T98 Y99 D100 I101 G102 Y103 S104 Y105 M106 K107 
ACA TAT GAT ATA GGC TAT AGT TAC ATG AAA 
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Figure S1. FPLC trace of W67F IsdG. The filtered lysate was loaded onto a nickel-charged 
HiTrap Chelating HP column (GE Healthcare) equilibrated with 50 mM Tris pH 7.4, 150 mM 
NaCl. The column was washed with a linear gradient of imidazole from 0 to 80 mM before 
W67F IsdG was eluted with 250 mM imidazole. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. FPLC trace of WT IsdG. The filtered lysate was loaded onto a nickel-charged HiTrap 
Chelating HP column (GE Healthcare) equilibrated with 50 mM Tris pH 7.4, 150 mM NaCl. The 
column was washed with a linear gradient of imidazole from 0 to 80 mM before WT IsdG was 
eluted with 250 mM imidazole. 
